Meeting to be held on October 23-24 hosted by Oppenheimer.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- CytomX Therapeutics price target raised to $6 from $3.50 at Barclays
- CytomX Therapeutics appoints Rachael Lester as chief business officer
- Oppenheimer positive on CytomX after Merus colon cancer data
- CytomX Therapeutics: Hold Rating Amid Awaited CX-801 Data and Market Potential
- CytomX Therapeutics initiated with an Overweight at Cantor Fitzgerald